| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/27/2002 | EP1181012A2 Intravenous valproate for acute treatment of migraine headache |
| 02/27/2002 | EP1181006A1 Methods for regulating the condition of mammalian keratinous tissue via topical application of phytosterol compositions |
| 02/27/2002 | EP1181001A2 Sunscreen composition containing sol-gel microcapsules |
| 02/27/2002 | EP1180991A2 Gambogic acid, analogs and derivatives as activators of caspases and inducers of apoptosis |
| 02/27/2002 | EP1180944A1 Compositions containing creatine in suspension |
| 02/27/2002 | EP1150990A4 Erythromycin a compounds and process for preparing the same |
| 02/27/2002 | EP1021198B1 Flavonolignan preparations, especially silymarin preparations |
| 02/27/2002 | EP1003559B1 Immobilization of vitamin a acid by cationic polyelectrolytes |
| 02/27/2002 | EP0970105B1 Process for preparing carboxamido-4-azasteroids |
| 02/27/2002 | EP0946156B1 Drinkable ibuprofen composition |
| 02/27/2002 | EP0939626B1 Galenic formula with extended release of milnacipran |
| 02/27/2002 | EP0939623B1 Oral delayed immediate release formulation and method of preparation therefor |
| 02/27/2002 | EP0927178B1 Tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
| 02/27/2002 | EP0915841B1 Anilinopeptide derivatives |
| 02/27/2002 | EP0914127B1 Antifungal composition with enhanced bioavailability |
| 02/27/2002 | EP0892789B1 Irreversible inhibitors of tyrosine kinases |
| 02/27/2002 | EP0865296B1 Influenza vaccine |
| 02/27/2002 | EP0859634B1 Pharmaceutical compositions containing platelet aggregation inhibitors |
| 02/27/2002 | EP0842193B1 Somatostatin-analogous cyclic peptides with inhibitory activity on growth hormone |
| 02/27/2002 | EP0828506B1 Endoparasiticidal agents |
| 02/27/2002 | EP0827545B1 Retroviral vectors |
| 02/27/2002 | EP0825991B1 Diaryldiamine derivatives and their use as delta opioid (ant)-agonists |
| 02/27/2002 | EP0817770B1 Nonpeptides as tachykinin antagonists |
| 02/27/2002 | EP0797441B1 Pharmaceutical composition comprising lamotrigine |
| 02/27/2002 | EP0792271B1 Furan derivatives for inhibiting pneumocystis carinii pneumonia, giardia lamblia and cryptosporidium parvum |
| 02/27/2002 | EP0792264B1 Sulfur-substituted azetidinone compounds useful as hypocholesterolemic agents |
| 02/27/2002 | EP0783495B1 Quinoxaline derivatives useful in therapy |
| 02/27/2002 | EP0782447B1 Use of prostaglandins for the manufacture of a medicament for prevention and treatment of secondary cataract |
| 02/27/2002 | EP0759300B1 process for producing molten granulated sucralfate preparations |
| 02/27/2002 | EP0731992B1 High-density interconnect technique |
| 02/27/2002 | EP0706385B1 Use of isovaleramide as a mild anxiolytic and mild sedative agent |
| 02/27/2002 | EP0687251B1 1,3-dihydroindol-2-one derivatives substituted in position 3 by a nitrogen group as vasopressin and/or ocytocine agonists and/or antagonists |
| 02/27/2002 | EP0651645B1 Medicament for inhibiting neutrophil elastase and cathepsin g |
| 02/27/2002 | EP0587645B1 Benzo- and pyridopyran derivatives having anxiolytic and anti-convulsant activity |
| 02/27/2002 | CN1337966A Hesperitin pro-forms with enhanced bioavailability |
| 02/27/2002 | CN1337965A 3,6-disubstituted penam sulfone derivatives as antibacteriuls |
| 02/27/2002 | CN1337964A Novel aralkyl amines of spirofuropyridines useful in therapy |
| 02/27/2002 | CN1337963A Pirazino (aza) indole derivatives |
| 02/27/2002 | CN1337962A Acetylenic ortho-sulfonamido and phosphinic acid amido bicyclic heteroaryl hydroxamic acids as TACE inhibitors |
| 02/27/2002 | CN1337961A Heteroaryl amidines, methyl amidiues and guanidines as protease inhibitors |
| 02/27/2002 | CN1337960A Piperdine and piperazine derivatives as inhibitors of the ABETA fibril formation |
| 02/27/2002 | CN1337959A 2-(2,6-dioxopiperidin-3-yl)-isoindoline derivatives, their preparation and their use as inhibitors of inflammatory cytokines |
| 02/27/2002 | CN1337958A Compounds and methods for modulation of estroglen receptors |
| 02/27/2002 | CN1337956A New Morpholinobenzamide salts |
| 02/27/2002 | CN1337955A Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents |
| 02/27/2002 | CN1337953A New thryoid receptor ligands and process II |
| 02/27/2002 | CN1337952A 2,3,4,5-tetrahydro-1H-[1,4] benzodiazepine-3-hydroxamic acid as matrix metalloproteinase inhibitors |
| 02/27/2002 | CN1337949A Heteroaryl acetylenic sulfonamide and phosphinic acid amide hydroxamic acid as TACE inhibitor |
| 02/27/2002 | CN1337948A Alkynyl containing hydroxamic acid derivatives, their preparation and their use as matrix metalloproteinase (MMP) inhibitors/TNF-alpha converting enzyme (TACE) inhibitors |
| 02/27/2002 | CN1337947A Acetylenic sulfonamide thiol TACE inhibitors |
| 02/27/2002 | CN1337946A S-nitrosothiols as agents for the treatment of circulatory dysfunctions |
| 02/27/2002 | CN1337945A Alkynyl containing hydroxamic acid compounds as TACE inhibitors |
| 02/27/2002 | CN1337944A Acetylenic beta-sulfonamido and phosphinic acid amide hydroxamic acid as TACE inhibitors |
| 02/27/2002 | CN1337937A Crystal polymorphism of aminoethylphenoxyacetic acid derivatives |
| 02/27/2002 | CN1337932A Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treamtent of respiratory diseases |
| 02/27/2002 | CN1337931A Retinoid antagonists and use thereof |
| 02/27/2002 | CN1337881A Use of phosphororganic compounds for the prophylactic and therapeutical treatment of infections |
| 02/27/2002 | CN1337880A HIV-1 mutation selecting from beta-2',3'-didehydro-2',3-dideoxy-5-fluorocytidine |
| 02/27/2002 | CN1337879A Use of angiotensin II receptor antagonists for treating acute myocardial infarction |
| 02/27/2002 | CN1337878A Methods for treating overian cancer, poly(phosphoester) compositions, and biodegradable articles for same |
| 02/27/2002 | CN1337851A Converting COX-2 inhibition compounds that are not COX-2 selective inhibitors to derivatives that are COX-2 selective inhibitors |
| 02/27/2002 | CN1337850A Amide derivatives for antiangiogenic and/or antitumorgenic use |
| 02/27/2002 | CN1337411A Chitosan aliphatic salt with slimming function and its prepn process |
| 02/27/2002 | CN1337395A Novel acardite compound, its preparation method and medicinal composition containing said compound |
| 02/27/2002 | CN1337249A Liposoluble Chinese medicine rectal suppository for treating acute and chronic prostatitis |
| 02/27/2002 | CN1337234A Compound alum powder and its prepn |
| 02/27/2002 | CN1337232A Application of sodium deoxy taurocholate as synergist for antituber culosis antibiotic |
| 02/27/2002 | CN1337231A Application of sodium taurocholate as synergist for antituberculosis antibiotic |
| 02/27/2002 | CN1337230A Application of Lavermit in preparing medicine for tetanic rachitis |
| 02/27/2002 | CN1337229A Bifonazole-containing medicine composition |
| 02/27/2002 | CN1337228A Application of lipoic acid for improving biological utilization ratio of mineral salt |
| 02/27/2002 | CN1337227A Soluble liquide preparation of liposoluble matter |
| 02/27/2002 | CN1337225A Transdermal physiotherapeutic medicine gel |
| 02/27/2002 | CN1079796C Novel N-7-heterocyclyl pyrrolo [2,3-D] pyridines and their use |
| 02/27/2002 | CN1079795C Stabilization and recovery method for tocotrienol and tocopherol products |
| 02/27/2002 | CN1079793C Process for preparation of enantiomerically pure substituted 1,4-dihydropyridine-3,5-dicarboxylic acid derivatives |
| 02/27/2002 | CN1079792C 酶抑制剂 Inhibitors |
| 02/27/2002 | CN1079791C Vitamin D. analogues |
| 02/27/2002 | CN1079788C Amide derivatives and their therapeutic use |
| 02/27/2002 | CN1079678C Long-lasting aqueous dispersions of pressure-resistant gas-filled microvesicles and methods for the preparation thereof |
| 02/27/2002 | CN1079676C Medicine treating burn and scald |
| 02/27/2002 | CN1079675C External use drug made of hops and vegetable oil |
| 02/27/2002 | CN1079672C Oral liquid alendronate formulations |
| 02/27/2002 | CN1079671C Combination treatment for inhibiting bone loss |
| 02/27/2002 | CN1079670C Sublingual or buccal pharmaceutical composition |
| 02/27/2002 | CN1079669C Anti-acne composition |
| 02/27/2002 | CN1079668C Injectable liposumal pharmaceutical preparation |
| 02/27/2002 | CN1079666C Dermatological preparation |
| 02/27/2002 | CN1079664C 口腔用组合物 Oral composition |
| 02/27/2002 | CN1079660C Miniming trichomadesis with anti-fungus compound and halogeno-anti-bacteria compound |
| 02/27/2002 | CN1079642C Novel embolizing compositions |
| 02/26/2002 | USRE37564 Composition for contraception |
| 02/26/2002 | US6350913 3-alkoxybenzylamine derivatives and their use as medicines for treating schizophrenia |
| 02/26/2002 | US6350907 Matrix metalloprotease inhibitors |
| 02/26/2002 | US6350890 Isolation of fatty acids or fatty esters from reaction |
| 02/26/2002 | US6350880 Crystalline or crystallized acid addition salt of losartan and purification method of losartan |
| 02/26/2002 | US6350877 Manufacturing process |
| 02/26/2002 | US6350869 Purification of antibiotic compound by salt formation of dicyclohexylamine |
| 02/26/2002 | US6350858 A polypeptide involved in controlling phosphate retention; diagnosis and therapy for chronic kidney failure, end stage kidney disease, uremic bone disease, and cancer |
| 02/26/2002 | US6350857 Fifty-four homologue (ffh) from streptococcus pneumoniae |